Is treatment of feline hypertrophic cardiomyopathy based in science or faith?. A survey of cardiologists and a literature search

Journal of Feline Medicine and Surgery

Volumn 13, Issue 7, 2011, Pages 487-497

  Rishniw, Mark ^a   Pion, Paul D ^a  

^a VETERINARY INFORMATION NETWORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CARDIOLOGY; CAT; CAT DISEASE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH CARE SURVEY; HYPERTROPHIC CARDIOMYOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIGION; SCIENCE; VETERINARY MEDICINE;

ANIMALS; CARDIOLOGY; CARDIOMYOPATHY, HYPERTROPHIC; CAT DISEASES; CATS; EVIDENCE-BASED MEDICINE; HEALTH CARE SURVEYS; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RELIGION AND MEDICINE; SCIENCE; VETERINARY MEDICINE;

FELIDAE;

EID: 79959572208     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2011.05.006     Document Type: Article

References (74)

1. Liu S.K., Tilley L.P., Lord P.F. Feline cardiomyopathy. Recent Adv Stud Cardiac Struct Metab 1975, 10:627-640.
2. Paige C.F., Abbott J.A., Elvinger F., Pyle R.L. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009, 234:1398-1403.
3. Coté E., Manning A.M., Emerson D., Laste N.J., Malakoff R.L., Harpster N.K. Assessment of the prevalence of heart murmurs in overtly healthy cats. J Am Vet Med Assoc 2004, 225:384-388.
4. Rush J.E., Freeman L.M., Fenollosa N.K., Brown D.J. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc 2002, 220:202-207.
5. Atkins C.E., Gallo A.M., Kurzman I.D., Cowen P. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 1992, 201:613-618.
6. Fox P.R., Liu S.K., Maron B.J. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995, 92:2645-2651.
7. Meurs K.M., Sanchez X., David R.M., et al. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 2005, 14:3587-3593.
8. Meurs K.M., Norgard M.M., Ederer M.M., Hendrix K.P., Kittleson M.D. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 2007, 90:261-264.
9. Carlos Sampedrano C., Chetboul V., Gouni V., Nicolle A.P., Pouchelon J.L., Tissier R. Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension. J Vet Intern Med 2006, 20:1106-1115.
10. Carlos Sampedrano C., Chetboul V., Mary J., et al. Prospective echocardiographic and tissue Doppler imaging screening of a population of Maine Coon cats tested for the A31P mutation in the myosin-binding protein C gene: a specific analysis of the heterozygous status. J Vet Intern Med 2009, 23:91-99.
11. Adin D.B., Diley-Poston L. Papillary muscle measurements in cats with normal echocardiograms and cats with concentric left ventricular hypertrophy. J Vet Intern Med 2007, 21:737-741.
12. MacDonald K.A., Kittleson M.D., Garcia-Nolen T., Larson R.F., Wisner E.R. Tissue Doppler imaging and gradient echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006, 20:627-634.
13. MacDonald K.A., Kittleson M.D., Kass P.H., Meurs K.M. Tissue Doppler imaging in Maine Coon cats with a mutation of myosin binding protein C with or without hypertrophy. J Vet Intern Med 2007, 21:232-237.
14. Koffas H., Dukes McEwan J., Corcoran B.M., et al. Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006, 20:65-77.
15. Schober K.E., Maerz I. Assessment of left atrial appendage flow velocity and its relation to spontaneous echocardiographic contrast in 89 cats with myocardial disease. J Vet Intern Med 2006, 20:120-130.
16. Cesta M.F., Baty C.J., Keene B.W., Smoak I.W., Malarkey D.E. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy. Vet Pathol 2005, 42:458-467.
17. Ferasin L., Sturgess C.P., Cannon M.J., Caney S.M., Gruffydd-Jones T.J., Wotton P.R. Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). J Feline Med Surg 2003, 5:151-159.
18. Laste N.J., Harpster N.K. A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977-1993. J Am Anim Hosp Assoc 1995, 31:492-500.
19. MacDonald K.A., Kittleson M.D., Larson R.F., Kass P., Klose T., Wisner E.R. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. J Vet Intern Med 2006, 20:1093-1105.
20. MacDonald K.A., Kittleson M.D., Kass P.H., White S.D. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy. J Vet Intern Med 2008, 22:335-341.
21. Taillefer M., Di Fruscia R. Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study. Can Vet J 2006, 47:437-445.
22. Smith S.A., Tobias A.H., Jacob K.A., Fine D.M., Grumbles P.L. Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 2003, 17:73-83.
23. Amberger C.N., Glardon O., Glaus T., et al. Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy: results of a prospective, open-label, multicenter clinical trial. J Vet Cardiol 1999, 1:19-26.
24. Rush J.E., Freeman L.M., Brown D.J., Smith F.W. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy. J Am Anim Hosp Assoc 1998, 34:38-41.
25. Bright J.M., Golden A.L., Gompf R.E., Walker M.A., Toal R.L. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy. J Vet Intern Med 1991, 5:272-282.
26. Fox P.R. Evidence for or against efficacy of beta-blockers and aspirin for management of feline cardiomyopathies. Vet Clin North Am Small Anim Pract 1991, 21:1011-1022.
27. Smith C.E., Rozanski E.A., Freeman L.M., Brown D.J., Goodman J.S., Rush J.E. Use of low molecular weight heparin in cats: 57 cases (1999-2003). J Am Vet Med Assoc 2004, 225:1237-1241.
28. Baty C.J. Feline hypertrophic cardiomyopathy: an update. Vet Clin North Am Small Anim Pract 2004, 34:1227-1234.
29. Ferasin L. Feline myocardial disease 2: diagnosis, prognosis and clinical management. J Feline Med Surg 2009, 11:183-194.
30. Watson A.D., Church D.B. Preferences of veterinarians for drugs to treat heart disease in dogs and cats. Aust Vet J 1995, 72:401-403.
31. Fox PR. Prospective, double-blinded, multicenter evaluation of chronic therapies for feline diastolic heart failure: interim analysis. Proceedings of the American College of Veterinary Internal Medicine; June 6-9, 2003; Charlotte, NC. (accessed Dec 8, 2010). http://beta.vin.com/%20Members/Proceedings/Proceedings.plx%3fCID%3dacvim2003%26PID%3dpr04461%26O%3dVIN.
32. MacDonald K.A., Kittleson M.D., Larson R.F., Kass P., Klose T., Wisner E.R. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. J Vet Intern Med 2006, 20:1093-1105.
33. Hogan DF. Update from the FAT CAT study on arterial thromboembolism. Proceedings of the American College of Veterinary Internal Medicine; June 4-7, 2008; San Antonio. (accessed Dec 8, 2010). http://beta.vin.com/Members/Proceedings/Proceedings.plx%3fCID%3dacvim2008%26PID%3dpr22820%26O%3dVIN.
34. Lamont L.A., Bulmer B.J., Sisson D.D., Grimm K.A., Tranquilli W.J. Doppler echocardiographic effects of medetomidine on dynamic left ventricular outflow tract obstruction in cats. J Am Vet Med Assoc 2002, 221:1276-1281.
35. Wey A., Kittleson M.D. Comparison of the efficacy of intravenous diltiazem and esmolol to reduce left ventricular outflow tract velocity and heart rate in cats with hypertrophic obstructive cardiomyopathy. J Vet Intern Med 2000, 14:335.
36. Cockcroft P., Holmes M. Handbook of evidence-based veterinary medicine 2003, Blackwell, Oxford, UK.
37. Bright J.M., Golden A.L. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats. Vet Clin North Am Small Anim Pract 1991, 21:1023-1034.
38. Mendinger T.L., Bruyette D.S. Feline hypertrophic cardiomyopathy. Compend Contin Educ Pract Vet 1992, 14:479-483. 486-88, 490-92.
39. Gruffydd Jones T.J., Wotton P.R. Cardiomyopathy and thromboembolism in cats. Vet Annu 1986, 26:348-360.
40. Freeman L.M. Nutritional management of feline heart disease. NAVC Clinician's Brief 2004, 15-17:79.
41. Smith S.A., Tobias A.H. Feline arterial thromboembolism: an update. Vet Clin North Am Small Anim Pract 2004, 34:1245-1271.
42. Dunn K. Hypertrophic cardiomyopathy. VN Times 2004, 4:14.
43. Falconer L., Atwell R. Feline aortic thromboembolism. Aust Vet Pract 2003, 33:20-32.
44. Falconer L., Atwell R. Haemostasis, anticoagulation and feline aortic thromboembolism. Aust Vet Pract 2003, 33:160-171.
45. Fuentes V.L. Diastolic function - is this the key to successful management of many feline cardiomyopathies?. J Feline Med Surg 2003, 5:51-56.
46. Fuentes V.L. Feline heart disease: an update. J Small Anim Pract 1992, 33:130-137.
47. Behrend E.N., Grauer G.F., Greco D.S. Feline hypertrophic cardiomyopathy, Part 1. Feline Pract 1996, 24:34-37.
48. Behrend E.N., Grauer G.F., Greco D.S. Feline hypertrophic cardiomyopathy. Part 3. Feline Pract 1997, 25:22-25.
49. Behrend E.N., Grauer G.F., Greco D.S. Feline hypertrophic cardiomyopathy, Part 2. Feline Pract 1997, 25:9-12.
50. Atkins C. Feline cardiomyopathy 1995, Publication Veterinary Continuing Education, Massey University, 33-41.
51. Rodriguez D.B., Harpster N. Treatment of feline hypertrophic cardiomyopathy. Compend Contin Educ Pract Vet 2002, 24:470-475.
52. Haggstrom J. Hypertrophic cardiomyopathy in cats - it used to be so simple!. J Feline Med Surg 2003, 5:139-141.
53. Bonagura J.D. Feline hypertrophic cardiomyopathy. Vet Q 1997, 19:s5-s6.
54. Rush J.E. Therapy of feline hypertrophic cardiomyopathy. Vet Clin North Am Small Anim Pract 1998, 28:1459-1479. ix.
55. Labuc R. Cardiomyopathy in the dog and cat - part II 1996, Publication Veterinary Continuing Education, Massey University, 137-46.
56. Pion P.D. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. Vet Clin North Am Small Anim Pract 1988, 18:79-86.
57. Reimer S.B., Kittleson M.D., Kyles A.E. Use of rheolytic thrombectomy in the treatment of feline distal aortic thromboembolism. J Vet Intern Med 2006, 20:290-296.
58. Freeman L.M., Brown D.J., Smith F.W., Rush J.E. Magnesium status and the effect of magnesium supplementation in feline hypertrophic cardiomyopathy. Can J Vet Res 1997, 61:227-231.
59. Schaub R.G., Gates K.A., Roberts R.E. Effect of aspirin on collateral blood flow after experimental thrombosis of the feline aorta. Am J Vet Res 1982, 43:1647-1650.
60. Bright J.M., Dowers K., Powers B.E. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury. Vet Ther 2003, 4:35-46.
61. Killingsworth C.R., Eyster G.E., Adams T., Bartlett P.C., Bell T.G. Streptokinase treatment of cats with experimentally induced aortic thrombosis. Am J Vet Res 1986, 47:1351-1359.
62. Behrend E.N., Grauer G.F., Greco D.S., Rose B.J., Thrall M.A.H. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats. J Am Anim Hosp Assoc 1996, 32:11-18.
63. Hogan D.F., Andrews D.A., Green H.W., Talbott K.K., Ward M.P., Calloway B.M. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004, 225:1406-1411.
64. Hogan D.F., Ward M.P. Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi. Am J Vet Res 2004, 65:715-719.
65. Hogan D.F., Andrews D.A., Talbott K.K., Green H.W., Ward M.P., Calloway B.M. Evaluation of antiplatelet effects of ticlopidine in cats. Am J Vet Res 2004, 65:327-332.
66. Bright J.M., Sullivan P.S., Melton S.L., Schneider J.F., McDonald T.P. The effects of n-3 fatty acid supplementation on bleeding time, plasma fatty acid composition, and in vitro platelet aggregation in cats. J Vet Intern Med 1994, 8:247-252.
67. Abbott J.A. Feline hypertrophic cardiomyopathy: an update. Vet Clin North Am Small Anim Pract 2010, 40:685-700.
68. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991, 324:781-788.
69. Patterson J., Fetzer D., Krall J., Wright E., Heller M. Eye patch treatment for the pain of corneal abrasion. South Med J 1996, 89:227-229.
70. Le Sage N., Verreault R., Rochette L. Efficacy of eye patching for traumatic corneal abrasions: a controlled clinical trial. Ann Emerg Med 2001, 38:129-134.
71. Gilbert R., Salanti G., Harden M., See S. Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002. Int J Epidemiol 2005, 34:874-887.
72. Reynolds C.A., Oyama M.A., Rush J.E., et al. Perceptions of quality of life and priorities of owners of cats with heart disease. J Vet Intern Med 2010, 24:1421-1426.
73. Jandrey K.E., Norris J.W., MacDonald K.A., Kittleson M.D., Tablin F. Platelet function in clinically healthy cats and cats with hypertrophic cardiomyopathy: analysis using the Platelet Function Analyzer-100. Vet Clin Pathol 2008, 37:385-388.
74. Stokol T., Brooks M., Rush J.E., et al. Hypercoagulability in cats with cardiomyopathy. J Vet Intern Med 2008, 22:546-552.